Integrative Potential of Majoon Suranjan in the Management of Varicose Veins: A Review of Unani Humoral Theory and Contemporary Molecular Mechanisms

Background: Chronic Venous Disease (CVD), traditionally known as Dawali, involves complex vascular remodelling. While the Unani System of Medicine (USM) has long utilised Majoon Suranjan (MS) for its resolvent (Muhallil) properties, its molecular interactions with modern vascular science remain underexplored. Objectives: This review aims to synthesise classical Unani humoral theories of venous stasis with modern molecular mechanisms, with a specific focus on the regulation of Matrix Metalloproteinases (MMPs) by the bioactive constituents of Majoon Suranjan. Methods: A comprehensive analysis of classical Unani texts (e.g., Al-Qanun Fi’l Tibb) was integrated with contemporary pharmacological data and bibliographic trends (2014–2024) regarding Majoon Suranjan (MS) and chief ingredient Colchicum luteum and its primary alkaloid, colchicine. Results: The study identifies a significant conceptual convergence between the Unani "atrabilious matter" (Sauda) and modern hemorheological stasis. Mechanistically, the Muhallil action of Majoon Suranjan aligns with the inhibition of MMP-9 and the NLRP3 inflammasome, which prevents the degradation of the extracellular matrix (ECM) and stabilises the venous wall. Furthermore, the polyherbal synergism of ingredients like Zingiber officinale and Piper longum enhances microcirculation and mitigates tropolone alkaloid toxicity. Conclusion: Majoon Suranjan serves as a scientifically plausible integrative therapy for varicose veins. Future clinical research utilising Doppler-derived hemodynamic and proteomic profiling is recommended to establish its role in standard vascular care.